News | March 15, 2011

Cobalt Chromium Stent Cleared in Europe

March 15, 2011 – A new chromium cobalt stent has received the CE mark market clearance in Europe. The Azule cobalt chromium stent, from OrbusNeich, combines the stent design of the its predecessor, the Blazer, with a delivery system with enhanced crossability and flexible deliverability.

The stent features the company’s dual helix design, offering conformability and radial strength on thin, flexible and low-profile cobalt chromium stent struts. The stent's tip length has been reduced from 5 mm to 4.25 mm, improving deliverability and crossability. The precise laser forming of the tip results in a lower lesion entry profile, and the controlled laser welding of the balloon to the catheter improves the stent's trackability and flexibility.

"Continuous technology advancement is mandated by our customers and the very nature of interventional cardiology," said Al Novak, OrbusNeich's chairman and CEO. "We believe the underlying deliverability of a stent is, and will continue to be, a critically important factor that we strive to improve."

For more information: www.OrbusNeich.com

Related Content

Biotronik Studies Demonstrate Efficacy of Minimizing Metal Burden in SFA Therapy
News | Stents Bare Metal| September 22, 2017
Physicians demonstrated that reducing metal burden in superficial femoral artery (SFA) therapy could effectively reduce...
Biotronik, PRO-Kinetic Energy cobalt chromium coronary stent system, FDA approval
Technology | Stents Bare Metal| February 15, 2017
The PRO-Kinetic Energy Cobalt Chromium (CoCr) Coronary Stent System from Biotronik has gained U.S. Food and Drug...
Biotronik Astron stent
Technology | Stents Peripheral| December 31, 2015
December 31, 2015 - The U.S.
Technology | Stents Bare Metal| December 09, 2015
Medinol U.S. recently opened their commercial business in Parsippany, New Jersey, followed by the launch of the...
News | Antiplatelet and Anticoagulation Therapies| June 11, 2015
Patients who received a bare metal coronary stent did not display significant differences in rates of adverse events...
Technology | July 22, 2014
July 22, 2014 — Boston Scientific announced it received U.S. Food and Drug Administration (FDA) approval for the Rebel...
Boston Scientific Rebel Platinum Chromium Coronary Stent System Bare Metal
News | March 13, 2014
Boston Scientific Corp. received CE marking for the Rebel Platinum Chromium Coronary Stent System, the company's latest...
Biosensors BioMatrix

The LEADERS Trial showed that the Biosensors BioMatrix, a drug-eluting stent with a biodegradable abluminal polymer coating, was functionally equivalent to a regular nonbiodegradable stent.

Feature | February 04, 2013 | Kamran Zamanian, Ph.D.
The interventional cardiology market includes, but is not limited to, drug-eluting stents, bare-metal stents,...
Overlay Init